학술논문
腹膜透析患者接種SARS-CoV-2疫苗現況分析－北區醫學中心經驗 / Current Status of SARS-CoV-2 Vaccination in Patients with Peritoneal Dialysis-One Hospital Experience
Document Type
Article
Author
廖秋萍 / Chiu-Ping Liao; 闕淑能 / Shu-Neng Chueh; 劉蕙婷 / Hui-Ting Liu; 陳怡婷 / Yi-Ting Chen; 楊紹佑 / Shao-Yu Yang; 姜至剛 / Chih-Kang Chiang; 林水龍 / Shuei-Liong Lin; 洪冠予 / Kuan-Yu Hung; 陳永銘 / Yung-Ming Chen
Source
腎臟與透析 / Kidney and Dialysis. Vol. 34 Issue 4, p199-204. 6 p.
Subject
Language
繁體中文
英文
英文
ISSN
2411-5347
Abstract
Total 453 patients with peritoneal dialysis were enrolled from June to November 2021. These patients were surveyed with questionnaire. Three hundred and fifty-six of whom (78.6%) had received two doses of COVID-19 vaccine, 37 patients (8.2%) only received one dose of COVID-19 vaccine, and 60 patients (13.2%) did not. Most of side effects after vaccination were local reactions, such as redness, swelling, and pain. As previous studies, the side effects of ChAdOx1 nCoV-19 (Oxford-AstraZeneca, AZ) vaccine were more severe in the first dose. However, the reaction of mRNA-1273 (Moderna) vaccine the second dose more severe than the first dose.